Literature DB >> 8213055

Neuropsychological performance in HIV-1-infected drug abusers.

M P Grassi1, C Perin, F Clerici, C Zocchetti, A Cargnel, A Mangoni.   

Abstract

Twenty-five HIV-seropositive drug abusers (DA+HIV+) (groups II-III and IV [A, C2 and E] of the CDC classification) were evaluated by use of the WAIS scale to determine any possible involvement of cognitive functions in the not yet overt phases of AIDS. The results were compared with those obtained in two control populations composed of 19 seronegative drug abusers (DA+HIV-) and 24 healthy subjects (DA-HIV-) to evaluate, in addition to the disease, the possible effect of the use of alcohol and toxic substances on cognitive performance. In spite of the small number of subjects, the study indicated that drug abuse is the main factor, among those analyzed, in determining a decline in cognitive functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213055     DOI: 10.1111/j.1600-0404.1993.tb04202.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Alcohol and HIV Infection.

Authors:  Steve Nelson; Gregory J Bagby
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

2.  Circulating proviral HIV DNA and HIV-associated dementia.

Authors:  Bruce Shiramizu; Suzanne Gartner; Andrew Williams; Cecilia Shikuma; Silvia Ratto-Kim; Michael Watters; Joleen Aguon; Victor Valcour
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

3.  Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Authors:  Bruce Shiramizu; Andrew E Williams; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.